R
ates of esophageal adenocarcinoma (EAC) have increased rapidly in the United States and much of western Europe, and 5-year survival continues to be poor. 1 Prevention and early detection efforts for EAC have focused on identifying persons with EAC precursor state, Barrett's esophagus, but the survival benefit has been disappointingly low.
Precise risk stratification could improve early identification of individuals who will develop EAC, allowing for such high-risk individuals to be targeted for new and evolving preventive and minimally invasive screening technologies. This underlying issue of efficiency is conceptually similar to the Gini coefficient, a widely accepted method to depict the income distribution of a group to assess wealth inequality. A Lorenz curve plots percentage of wealth against the percentage of the population; perfect wealth distribution would result in a slope of 1 and a Gini coefficient of 0, whereas severe wealth inequity results in higher Gini values closer to 1. Some examples of Gini coefficients are shown in Supplementary Figure 1 . In this article, we use relative risks of stratified groups to construct Lorenz curves and quantitively analyze the distribution of EAC burden in the US population, for which a higher Gini coefficient indicates more efficient risk stratification.
Methods
Lorenz curves and Gini coefficients were constructed for 3 strategies: (1) perfect compliance 2 and (2) current compliance to using only symptomatic gastroesophageal reflux disease (GERD) to triage patients for endoscopic EAC screening 2 ; and (3) potential risk stratification using 5 risk factors including race, sex, smoking status (never smoker vs ever smoker), obesity (body mass index categories with normal, overweight, and obese), and GERD symptoms that resulted in 48 subgroups. For the third strategy, we estimated the relative risk for EAC and percent population of the subgroups from published data [3] [4] [5] and databases. [6] [7] [8] Results Figure 1A presents Lorenz curves with cumulative EAC cases on the x-axis and cumulative US population on the yaxis. First, we depicted the Lorenz curves that are consistent with the previously recommended strategy targeting the presence of GERD symptoms as the primary risk factor to triage patients for endoscopic screening. The yellow curve represents perfect adherence with a Gini coefficient of 0.39, where 17.5% of the population with symptomatic GERD can be used to identify approximately 56% of EAC cases. The red curve depicts the GERD screening strategy with current adherence rates with Gini coefficient of 0.05, where 7% of EAC cases are identified within approximately 2% of the population.
The potential risk-stratification method, depicted in green, to improve the identification of high-risk patients using 5 risk factors (race, sex, smoking status, obesity, and GERD symptoms) resulted in a Gini coefficient of 0.68. Figure 1B lists the 48 subgroups representing all combinations of the 5 risk factors, ordered from highest to lowest relative risk of EAC compared with the reference risk group (nonwhite women who do not smoke, normal weight, without GERD symptoms). Each row with diminishing relative risk in Figure 1B (from top to bottom) corresponds to a point on the green curve of the Lorenz curve in Figure 1A (from left to right). Some specific green points are highlighted because they reflect unique profiles, such as the first nonwhite group, first group without GERD symptoms, and first female group.
Discussion
Although there is no correct or established cutoff, one intuitive or visual inflection point is where 80% of patients who will develop EAC are identified, achieved by targeting 29% of the population (shaded in darker green). To identify 90% of EAC cases would require targeting more than 42% of the population.
Our Lorenz curve and Gini coefficient calculations not only highlight the inefficiency of current practice of GERD-only centric strategy, but also exhibit the potential synergic effects among risk factors. For example, the first female group in Figure 1B , with 4 other risk factors present (smoking, obese, GERD symptoms, and white) would still be considered having higher risk of EAC compared with the white male smoking group. The improvements in efficiency shown by our results could be further enhanced with the addition of any independent molecular biomarkers that are currently an area of intense research.
Although our analysis underscores the potential for more efficient screening, it does not suggest or shed light on the optimal screening regimen that should be used or how effective such screening will be. Our observations also serve as a call for more quantitative studies and analyses on risk stratification to guide targeted screening for EAC and other less common cancer screening. 5% of the population with symptomatic GERD can be used to identify approximately 56% of EAC cases. Gini coefficient ¼ 0.39. The green curve represents the potential strategy to improve the identification of high-risk patients that incorporates 5 risk factors: race, sex, smoking status (never smoker vs ever smoker), obesity (BMI categories), and GERD symptoms. Gini coefficient ¼ 0.68. (B) Stratified risk groups ranked by relative risk of EAC. Subgroups in US population stratified by 5 risk factors (smoking, BMI, GERD, race, and sex) and ranked by relative risk of EAC to the reference group (last row). The relative risk is calculated using proportion and odds ratio of EAC of each risk group, depicted in blue bar. BMI, body mass index; G, Gini coefficient.
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Supplementary Methods
To construct the Lorenz curve for the potential risk stratification method, we divided the total population into 48 subgroups by 5 risk factors (race, sex, smoking status, obesity, and GERD symptoms) and estimated the percent of the population and percent of EAC cases captured for each subgroup. Although a traditional Lorenz curve has the cumulative percent of population on the x-axis and the cumulative share of wealth (income or expenditure) on the y-axis, we transposed the 2 axes such that the percent of EAC cases corresponds to the xaxis to more readily visualize the higher risk groups concentrated toward the left side of x-axis and any potential cutoff for EAC screening along the Lorenz curve.
The percent population for the subgroups was informed from 3 databases: (1) Barrett's and Esophageal Adenocarcinoma Consortium (BEACON); (2), the National Health and Nutrition Examination Survey (NHANES); and (3) NCI's Surveillance, Epidemiology, and End Results (SEER) Program. Specifically, the proportions of body mass index (BMI) categories (<25, 25-30, !30), race (white, nonwhite), sex, and smoking status (ever smoker, never smoker) were calculated from NHANES, 6 whereas the proportions of the GERD symptoms stratified by the other 4 risk factors were calculated from BEACON. 7 We assume these estimates are generalizable.
We then calculated the relative risk of EAC for the subgroups compared with baseline group: nonwhite female nonsmoker with BMI <25 and no GERD symptoms. Risk ratios between race and sex strata were calculated by averaging SEER EAC incidence rates from 2009 to 2013 for population of age 60-64 (SEER ver8.3.2). 2 The risk ratios for BMI, GERD, and smoking status were estimated from odds ratios reported from previous BEACON studies because of rare events. [3] [4] [5] These risk ratio estimates were listed by risk factors in Supplementary Table 1 . We assumed multiplicative effects across strata.
Percent of EAC cases corresponding to each risk group was then calculated using previously estimated percent population and relative risk of EAC, as shown below:
With risk group i, i ¼ 1,2,3. 48:
where RR is relative risk and baseline risk is risk of EAC for nonwhite, female, never smoker, BMI <25, no GERD. For a particular risk group k, k˛ [1, 48] : We then ranked the 48 subgroups by decreasing relative risk of EAC compared with the baseline group, as shown in Figure 1B . Finally, we plotted the Lorenz curve with x-axis representing cumulative percent of EAC cases, and y-axis representing cumulative percent of population, corresponding to the green curve in Figure 1A .
The Gini coefficient 8 was calculated for all 3 Lorenz curves using the following formula: G ¼ 2 Â ð 0:5 À Area under the Lorenz CurveÞ
Other investigators have estimated Lorenz curves from case-control study, depicting disease burden distribution within a population as a measure of efficiency. 9 
